Bacchus takes thrombolysis device to the US
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale Bacchus Vascular's next generation, minimally invasive thrombolysis system for treating peripheral arterial disease and deep venous thrombosis.